It is very uncertain whether summary of findings table ‐ Planned hospital birth changes baby not breastfed compared with planned home birth (very low certainty).

1 finding from 1 review

Planned hospital birth compared with planned home birth for pregnant women at low risk of complications 2023 · Cochrane Headline outcomes only
OR 1.84 [0.15, 23.38]
1 study · 11 participants
Very low

Summary of findings table ‐ Planned hospital birth vs Planned home birth

Maternal satisfaction ‐ not reported · Pregnant women at low risk of complications

The review found no eligible studies for this question.

1 finding from 1 review

Planned hospital birth compared with planned home birth for pregnant women at low risk of complications 2023 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Serenoa repens vs placebo or no intervention

Urologic symptom scores · men with lower urinary tract symptoms secondary to benign prostatic obstruction

Serenoa repens showed no clear difference in urologic symptom scoreMeasured by IPSS scores (range 0 to 35)Higher… compared with placebo or no intervention (high certainty).

1 finding from 1 review

Serenoa repens for the treatment of lower urinary tract symptoms due to benign prostatic enlargement 2023 · Cochrane Headline outcomes only
no estimate extracted
9 studies · 1681 participants
High

Serenoa repens vs placebo or no intervention

QoL · men with lower urinary tract symptoms secondary to benign prostatic obstruction

Serenoa repens showed no clear difference in quality of lifeMeasured by IPSS‐QoL score (range 0 to 6) compared with placebo or no intervention (high certainty).

1 finding from 1 review

Serenoa repens for the treatment of lower urinary tract symptoms due to benign prostatic enlargement 2023 · Cochrane Headline outcomes only
no estimate extracted
5 studies · 1001 participants
High

Serenoa repens vs placebo or no intervention

Adverse eventsCumulative incidence · men with lower urinary tract symptoms secondary to benign prostatic obstruction

Serenoa repens showed no clear difference in adverse eventsCumulative incidence compared with placebo or no intervention (moderate certainty).

1 finding from 1 review

Serenoa repens for the treatment of lower urinary tract symptoms due to benign prostatic enlargement 2023 · Cochrane Headline outcomes only
RR 1.01 [0.77, 1.31]
12 studies · 2399 participants
Moderate

Serenoa repens in combination with other phytotherapy vs placebo or no intervention

Urologic symptom scores · men with lower urinary tract symptoms secondary to benign prostatic obstruction

Serenoa repens in combination with other phytotherapy showed no clear difference in urologic symptom scoreMeasured by IPSS scores (range 0 to 35)Higher… compared with placebo or no intervention (low certainty).

1 finding from 1 review

Serenoa repens for the treatment of lower urinary tract symptoms due to benign prostatic enlargement 2023 · Cochrane Headline outcomes only
no estimate extracted
4 studies · 460 participants
Low

Serenoa repens in combination with other phytotherapy vs placebo or no intervention

QoL · men with lower urinary tract symptoms secondary to benign prostatic obstruction

1 finding from 1 review

Serenoa repens for the treatment of lower urinary tract symptoms due to benign prostatic enlargement 2023 · Cochrane Headline outcomes only
no estimate extracted
2 studies · 265 participants
Very low

Serenoa repens in combination with other phytotherapy vs placebo or no intervention

Adverse eventsCumulative incidence · men with lower urinary tract symptoms secondary to benign prostatic obstruction

Serenoa repens in combination with other phytotherapy showed no clear difference in adverse eventsCumulative incidence compared with placebo or no intervention (low certainty).

1 finding from 1 review

Serenoa repens for the treatment of lower urinary tract symptoms due to benign prostatic enlargement 2023 · Cochrane Headline outcomes only
RR 0.91 [0.58, 1.41]
4 studies · 481 participants
Low

Probiotics vs control

Necrotising enterocolitis · very preterm or very low birth weight infants

1 finding from 1 review

Probiotics to prevent necrotising enterocolitis in very preterm or very low birth weight infants 2023 · Cochrane Headline outcomes only
no estimate extracted
57 studies · 10918 participants
Low

Probiotics vs control

Mortality before hospital discharge · very preterm or very low birth weight infants

1 finding from 1 review

Probiotics to prevent necrotising enterocolitis in very preterm or very low birth weight infants 2023 · Cochrane Headline outcomes only
no estimate extracted
54 studies · 10484 participants
Moderate

Probiotics vs control

Late‐onset invasive infection (before hospital discharge) · very preterm or very low birth weight infants

1 finding from 1 review

Probiotics to prevent necrotising enterocolitis in very preterm or very low birth weight infants 2023 · Cochrane Headline outcomes only
no estimate extracted
49 studies · 9876 participants
Moderate

Probiotics vs control

Neurodevelopmental disability · very preterm or very low birth weight infants

1 finding from 1 review

Probiotics to prevent necrotising enterocolitis in very preterm or very low birth weight infants 2023 · Cochrane Headline outcomes only
no estimate extracted
5 studies · 1518 participants
Low

Probiotics vs control

Necrotising enterocolitis · extremely preterm or extremely low birth weight infants

1 finding from 1 review

Probiotics to prevent necrotising enterocolitis in very preterm or very low birth weight infants 2023 · Cochrane Headline outcomes only
no estimate extracted
10 studies · 1836 participants
Low